Drug discovery through the isolation of natural products from Burkholderia

Adam Foxfire,Andrew Riley Buhrow,Ravi S. Orugunty,Leif Smith

DOI: https://doi.org/10.1080/17460441.2021.1877655

2021-01-29

Expert Opinion on Drug Discovery

Abstract:<span><b>Introduction</b>: The increasing threat of antibiotic-resistant pathogens makes it imperative that new antibiotics to combat them are discovered. <i>Burkholderia</i> is a genus of Gram-negative, non-sporulating bacteria. While ubiquitous and capable of growing within plants and groundwater, they are primarily soil-dwelling organisms. These include the more virulent forms of <i>Burkholderia</i> such as <i>Burkholderia mallei, Burkholderia pseudomallei</i>, and the <i>Burkholderia cepacia</i> complex (Bcc). <b>Areas covered</b>: This review provides a synopsis of current research on the natural products isolated from the genus <i>Burkholderia</i>. The authors also cover the research on the drug discovery efforts that have been performed on the natural products derived from <i>Burkholderia</i>. <b>Expert opinion</b>: Though <i>Burkholderia</i> has a small number of pathogenic species, the majority of the genus is avirulent and almost all members of the genus are capable of producing useful antimicrobial products that could potentially lead to the development of novel therapeutics against infectious diseases. The need for discovery of new antibiotics is urgent due to the ever-increasing prevalence of antibiotic-resistant pathogens, coupled with the decline in the discovery of new antibiotics.</span>

pharmacology & pharmacy